Launch your Graphy
There are no items in your cart
Add More
Add More
| Item Details | Price | ||
|---|---|---|---|
Semaglutide in Schizophrenia: A Step Forward in Managing Metabolic Health?
access_time 2026-08-31T15:34:06.751Z face TIPPS Academic Coordinators
Semaglutide in Schizophrenia: A Step Forward in Managing Metabolic Health? - Dr Samrudhi Patil Semaglutide in Schizophrenia: A Step Forward in Managing Metabolic Health? Managing schizophrenia often extends well beyond controlling psychiatric symptoms. Weight gain and metabolic complications can be...
Delirium - APA guidelines 2025
access_time 1758110280000 face Dr. Rishikesh Behere
Delirium - APA guidelines 2025 Prevention and treatment of Delirium Prevention and treatment of Delirium - APA guideline 2025 This guideline from the American Psychiatric Association (APA), aims to enhance the quality of care for patients with delirium and prevent its development in at-risk individ...
Do antidepressants increase risk of ALS? Correlation is not Causation
access_time 2025-07-10T07:31:42.466Z face Dr Naren Rao
Do antidepressants increase risk of ALS? Correlation is not Causation Why Context Matters More Than Headlines ✍️ Dr. Naren P Rao | Medical Director & Senior Consultant Psychiatrist, Manoshanti Recently, a patient sent me a photo of a newspaper headline claiming that antidepressants, anti-anxiety me...
Esketamine monotherapy in depression
access_time 1751819760000 face Dr Rishikesh Behere
Journal Club July 2025 Esketamine Monotherapy for Treatment-Resistant Depression (TRD) JANIK ET AL, JAMA PSYCHIATRY ONLINE 2ND JULY 2025 Esketamine Monotherapy for Treatment-Resistant Depression (TRD) Introduction * Major Depressive Disorder (MDD) is a leading cause of disability and shortens life ...
TIPPS BULLETIN Sept2022
access_time 2022-09-05T12:33:12.042Z face TIPPS Academic Coordinators
TIPPSBULLETINSept2022 Read here READ HERE ...